SCHEMBL15522697

SCHEMBL15522697

O=C(Cc1ccc(C(O)CCCc2ccccc2)cc1)NO

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 6/20 0.60
HDAC6 Q9UBN7 3/20 0.60
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
HDAC1 Q13547 11/20 0.55
HDAC2 Q92769 3/20 0.54
HDAC3 O15379 2/20 0.54
HDAC5 Q9UQL6 2/20 0.54
GAA P10253 1/20 0.51
HPGD P15428 1/20 0.51
ALOX5 P09917 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
CNR2 P34972 1/20 0.50
TRPV1 Q8NER1 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15522657 0.96 HDAC8 (0.57) HDAC8HDAC6MEN1KMT2AHDAC1
SCHEMBL15522599 0.86 HDAC8 (0.57) HDAC8HDAC6MEN1KMT2AHDAC1
SCHEMBL4581295 0.85 HDAC8 (0.78) HDAC8HDAC6MEN1KMT2AHDAC1
SCHEMBL4580449 0.85 HDAC8 (0.78) HDAC8HDAC6MEN1KMT2AHDAC1
SCHEMBL4578244 0.84 HDAC1 (0.52) HDAC8HDAC6MEN1KMT2AHDAC1
SCHEMBL4579041 0.83 HDAC8 (0.75) HDAC8HDAC6MEN1KMT2AHDAC1
SCHEMBL6388052 0.83 HDAC1 (0.63) HDAC8HDAC6HDAC1HDAC2HDAC3
SCHEMBL15522546 0.82 HDAC8 (0.54) HDAC8HDAC6MEN1KMT2AHDAC1
SCHEMBL15522636 0.82 HDAC8 (0.54) HDAC8HDAC6MEN1KMT2AHDAC1
SCHEMBL4580234 0.80 ADRB3 (0.54) HDAC8HDAC1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140081017-A1 Histone Deacetylase Inhibitors for Enhancing Activity of Antifungal Agents METHYLGENE INC. (CA) 2014-03-20 US claimed
WO-2014041424-A1 HISTONE DEACETYLASE INHIBITORS FOR ENHANCING ACTIVITY OF ANTIFUNGAL AGENTS METHYLGENE INC. (CA) 2014-03-20 WO claimed
US-20140081017-A1 Histone Deacetylase Inhibitors for Enhancing Activity of Antifungal Agents METHYLGENE INC. (CA) 2014-03-20 US disclosed
US-20140081017-A1 Histone Deacetylase Inhibitors for Enhancing Activity of Antifungal Agents METHYLGENE INC. (CA) 2014-03-20 US disclosed
US-20140081017-A1 Histone Deacetylase Inhibitors for Enhancing Activity of Antifungal Agents METHYLGENE INC. (CA) 2014-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140081017-A1 Histone Deacetylase Inhibitors for Enhancing Activity of Antifungal Agents HDAC1, HDAC5, HDAC7 HDAC8 8/4885HDAC6 10/4885MEN1 1878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.